Primegen Healthcare Laboratories Private Limited, a active private limited company, was established on 28 January 2019 in Saidapet, Tamil Nadu, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U85310TN2019PTC127148. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
Formerly known as Primegen Health Sciences Private Limited. It upholds a compliant status. Employing 28 professional, Its leadership includes Ashiya Fathima (Director), Mayavan Sreedhar (Director). It holds ₹3.44 Cr open charges and ₹6.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No 30 36 1 23Rd Street, Thillai Ganga Nagar, Saidapet, Tamil Nadu, 600061.
U85310TN2019PTC127148
127148
28 January 2019
₹2.00 Cr
₹2.00 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Primegen Healthcare Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashiya Fathima | Director | 28 Jan 2019 | Current |
| Mayavan Sreedhar | Director | 28 Jan 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Primegen Healthcare Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.46% increase. The company also saw a substantial improvement in profitability, with a 29.69% increase in profit. The company's net worth Soared by an impressive increase of 23.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Primegen Healthcare Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹34,380,000.00
₹65,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jul 2022 | The South Indian Bank Limited | ₹3.00 Cr | Open |
| 26 Jul 2021 | Indian Bank | ₹4.38 M | Open |
| 16 Aug 2022 | Idbi Bank Limited | ₹5.00 M | Satisfied |
| 29 Jan 2022 | Idbi Bank Limited | ₹2.00 Cr | Satisfied |
| 22 Jul 2021 | Others | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Primegen Healthcare Laboratories has a workforce of 28 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Primegen Healthcare Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Primegen Healthcare Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Primegen Healthcare Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Primegen Healthcare Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
The activity A charge with The South Indian Bank Limited of Rs. 3.00 Cr registered on 18 Jul 2022 with Charge ID 100600477 was modified on 21 Sep 2023. was completed.
Progress on A charge registered on 16 Aug 2022 via Charge ID 100618854 with Idbi Bank Limited was fully satisfied on 07 Aug 2023. was documented.
A charge registered on 29 Jan 2022 via Charge ID 100538874 with Idbi Bank Limited was fully satisfied on 07 Aug 2023. was recorded as a recent event.
Progress on A charge registered on 22 Jul 2021 via Charge ID 100466518 with Others was fully satisfied on 20 Feb 2023. was documented.
The CIN of Primegen Healthcare Laboratories Private Limited is U85310TN2019PTC127148.
Primegen Healthcare Laboratories Private Limited is headquartered at No 30 36 1 23Rd Street, Thillai Ganga Nagar, Saidapet, Tamil Nadu, 600061.
Primegen Healthcare Laboratories Private Limited was incorporated on 28 January 2019.
The current directors of Primegen Healthcare Laboratories Private Limited are
The primary industry of Primegen Healthcare Laboratories Private Limited is Hospital And Medical Care.
Primegen Healthcare Laboratories Private Limited is unlisted.
The authorized capital of Primegen Healthcare Laboratories Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Primegen Healthcare Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX